Non-Alcoholic Fatty Liver Disease (NAFLD)
Also known as: MAFLD · Hepatic Steatosis
NAFLD is hepatic fat accumulation in the absence of significant alcohol use. It is strongly tied to insulin resistance and metabolic syndrome and can progress to NASH and cirrhosis.
What you need to know
NAFLD is the most common chronic liver condition in adults. Provider-reviewed care evaluates ALT, AST, GGT, fasting insulin, A1C, lipids, and imaging or elastography when indicated. Treatment centers on insulin-sensitizing therapies, weight reduction, and metabolic optimization.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.